Freedom of Information Disclosure Log 2016-2017

Documents disclosed in response to Freedom of Information (FOI) requests

Page last updated: 17 August 2017

All Australian Government agencies are required to publish a list of documents obtained under Freedom of Information (FOI), within 10 working days of the applicant receiving the documents.

Documents disclosed in response to an FOI request are subject to the following exceptions:
personal information or information about the business, commercial, financial or professional affairs of any person if publication would be unreasonable;
information determined by the Australian Information Commissioner not to be disclosed;
information that cannot reasonably practicably be published because of required deletions to the document.
In the spirit of promoting greater openness in government, the Department of Health (Health) maintains a list of documents disclosed under the FOI Act (with redactions). It is hoped that this measure will enable members of the public and the media to quickly and easily obtain access to material which has already been disclosed under the FOI Act.

The Health FOI Disclosure Log contains documents which can be downloaded. Due to the historical nature of the documents they are not in an accessible format. Members of the public that cannot access this format can contact Health to discuss alternative access arrangements.

Post:
Cabinet and FOI Section (MDP 41)
Department of Health
GPO Box 9848
CANBERRA ACT 2601
AUSTRALIA

Telephone:

(02) 6289 1666 (within Australia)
+61 2 6289 1666 (International)

Email: foi@health.gov.au

A list of documents disclosed in 2016-17 in response to Freedom of Information (FOI) requests.

FOI NumberDate of AccessSummary of FOI Request (link to documents)Access and Number of DocumentsOther Information
304-1617 24 August 2017 The Deloitte Access Economics evaluation of the diagnostic imaging sector.

FOI Request 304-1617 Document
1 document partial release
209-1617 20 June 2017 Copies of the final and draft reports of the National Alcohol Harm Harm Reduction Strategy Qualitative Evaluation of Resources Report as well as data and questions used.

FOI Request 209-1617 Document
3 documents full release
281-1617 16 June 2017 Documents where the Department has given consideration to the regulatory classification of risk-reduced tobacco products

FOI Request 281-1617 Document
2 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
220-1617 9 June 2017 Section 100 Drug Review as detailed on the AHA website. A copy of the final review of the continuing medication program carried out and funded by the Australian Government.

FOI Request 220-1617 Document
42 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
219-1617 18 May 2017 Reports or correspondence regarding the performance; accreditation; adverse incidents; concerns or complaints about a nursing home in South Australia

FOI Request 219-1617 Document
9 documents partial release
282-1617 16 May 2017 Laboratory report on Plexus Slim Accelerator

These documents are available on the TGA Disclosure log
5 documents released in full

154-1617 11 May 2017 Correspondence and other documentation relating to the offer and provision of services by Deloitte Access Economics to the Review of Pharmacy Remuneration and Regulation.

FOI Request 154-1617 Document
3 documents full release, 137 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
280-1617 11 May 2017 List of products approved under Special Access Scheme Category B between Jan 2016 to Dec 2016

These documents are available on the TGA Disclosure log
3 documents released in full

228-1617 5 May 2017 Documents relating to the marketing or advertising the Department has undertaken in relation to the drug Mifepristone, also known as RU486

FOI Request 228-1617 Document
4 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
130-1617 01 May 2017 Documents related to "Metformin modified release supply crisis"

FOI Request 130-1617 Document
3 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
217-1617 27 April 2017 Request for documents where the outcome of any enterprise bargaining ballots were communicated to the Department by the entity who undertook the ballots.

FOI Request 217-1617 Document
2 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
256-1617 21 April 2017 Request for number of departmental staff subject to disciplinary proceedings in the years 2015 and 2016, including the reasons for disciplinary action.

FOI Request 256-1617 Document
1 document full release
211-1617 21 April 2017 Documents that articulate the My Aged Care contact centre process required to appoint a legal representative for a client in My Aged Care

FOI Request 211-1617 Document
3 documents full release
206-1617 18 April 2017 Request for document which describes the data provided to the external agency responsible for conducting the ballot(s) for Enterprise Agreements put to staff for a vote.

FOI Request 206-1617 Document
5 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
098-1617 18 April 2017 Briefs or submissions from the Federal Health Department to the Office of the Federal Health Minister which mentioned the Tobacco Plain Packaging Act in relation to plain packaging between 26/7/2016 and 7/10/2016.

FOI Request 098-1617 Document
6 documents partial release
252-1617 12 April 2017 2nd reading speeches for the National Health Security Bill 2007 and Quarantine Amendment (National Health Security) Bill 2008. Input provided for 2nd reading speeches for Biosecurity Bill 2012 and Biosecurity Bill 2014

FOI Request 252-1617 Document
4 documents full release
201-1617 12 April 2017 Contracts, agreements or MOU between Department of Health and the NHMRC on the decision to revise the 2009 Australian Guidelines to reduce health risks from drinking alcohol.

FOI Request 201-1617 Document
2 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
264-1617 10 April 2017 Request for a list of briefs created in preparation for the 2016-17 Additional Estimates.

FOI Request 264-1617 Document
1 document full release
250-1617 31 March 2017 Ernst and Young to conduct a review of the prudential regulation of aged care providers and lump sum payments.

FOI Request 250-1617 Document
1 document full release
129-1617 27 March 2017 Request for receipts or other proof of purchase of tobacco products purchases by employees of the Federal Health Department, on behalf of the Federal Health Department, for the purposes of compliance with activity in the financial years 2011-12, 2012-13 and 2013-14.

FOI Request 129-1617 Document
33 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
115-1617 27 March 2017 Request for documents relating to the negotiation of the strategic agreement between Government and Medicines Australia

FOI Request 115-1617 Document
43 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
152-1617 22 March 2017 Request for meeting minutes for the Tobacco Plain Packaging Enforcement Committee for the past two years.

FOI Request 152-1617 Document
16 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
097-1617 20 March 2017 Correspondence sent from the Federal Health Department to manufacturers/wholesalers/importers regulated by the Tobacco Plain Packaging Act 2011 regarding breaches of the Act alleged to have been committed by the manufacturers/wholesalers/importers.

FOI Request 097-1617 Document
42 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
187-1617 20 March 2017 The incoming briefs prepared for the Minister of Health and Minister for Sport

FOI Request 187-1617 Document
1 document partial release
172-1617 14 March 2017 All correspondence between the Minister and businesswoman Sarina Russo

FOI Request 172-1617 Document
2 documents full release
131-1617 01 March 2017 Documents relating to Targocid

These documents are available on the TGA Disclosure log
15 document released in full, 3 documents released with redactions

181-1617 16 February 2017 Request for fact sheet on Continuing Medication Program

FOI Request 181-1617 Document
1 document partial release
266-1516 14 February 2016 Product information about Viagra

These documents are available on the TGA Disclosure log
2 documents released in full

145-1617 7 February 2017 Media Unit documents relating to Katungul Aboriginal Corporation Community and medical Services

FOI Request 145-1617 Document
1 document full release
155-1617 7 February 2017 Correspondence and other communication with the Australian Tax Office in relation to the Review of Pharmacy Remuneration and Regulation

FOI Request 155-1617 Document
6 documents partial release
111-1617 27 January 2017 Draft Regulation Impact Statement on Tobacco Product Content Regulation and Disclosure Requirements for Tobacco Products. Literature Review: The Effects of Cigarette Additives on Cigarette Palability

FOI Request 111-1617 Document
2 documents partial release
149-1617 11 January 2017 Policy on long service leave

FOI Request 149-1617 Document
1 document full release
137-1617 22 December 2016 Published accommodation prices over the legislated maximum (currently a lump sum of $550,000).

FOI Request 137-1617 Document
1 document full release
099-1617 21 December 2016 Details of the Section 19(2) exemption under the Health Insurance Act 1973 in relation to a specific location.

FOI Request 099-1617 Document
2 documents partial release
132-1617 15 December 2016 List of briefs created in preparation for the 2016-2017 Supplementary Budget Estimates

FOI Request 132-1617 Document
1 document full release
088-1617 12 December 2016 The Boston Consulting Group analysis of current Approved (Pathology) Collection Centre Rental Arrangements

FOI Request 088-1617 Document
1 document partial release
009-1617 1 December 2016 Various Medical Devices

These documents are available on the TGA Disclosure log
5 document released in full, 8 documents released with redactions

209-1516 11 November 2016 Regulatory status of fluoride in drinking water

These documents are available on the TGA Disclosure log
24 documents released in full, 2 documents released with redactions

In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
270-1516 1 November 2016 Request for Tender or Quote associated with CN3347202 and awarded to McKinsey Pacific Rim

FOI Request 270-1516 Document
2 documents partial release
067-1617 1 November 2016 Minutes in relation to the Provision of Guidance and Training on Forced Adoption for Health Professionals project

FOI Request 067-1617 Document
5 documents partial release
035-1617 31 October 2016 Documents sought in relation to transfer of MBS & PBS data to ABS for the purposes of National Mental Health Commission project

FOI Request 035-1617 Document
13 documents partial release
068-1617 17 October 2016 Special Access Scheme Category A

These documents are available on the TGA Disclosure log
1 document released in full, 0 documents released with redactions

016-1617 30 September 2016 The current incoming government brief

FOI Request 016-1617 Document
1 document partial release
005-1617 23 September 2016 Clinical Trials re: Eculizumab

These documents are available on the TGA Disclosure log
1 document released in full

024-1617 22 September 2016 Access to documents relating to the amendment to item 30177 in the Medicare Benefits Schedule that took effect on 1 January 2016.

FOI Request 024-1617 Document
15 documents full release. 1 document partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
054-1617 21 September 2016 Financial Year 2015-16 Bulk Billing Rate for total Medicare and GP attendances by electorate

FOI Request 054-1617 Document
1 document full release
007-1617 20 September 2016 Historical PO - Scitropin, Testosterone, Primoteston

These documents are available on the TGA Disclosure log
3 document released in full

Document 3 relates to business affairs and in accordance with section 11C(1) will not be published.
222-1516 19 September 2016 Tafenoquine

These documents are available on the TGA Disclosure log
97 document released in full

056-1617 16 September 2016 Documents for Medical Devices on the ARTG

These documents are available on the TGA Disclosure log
6 document released in full, 0 documents released with redactions

021-1617 7 September 2016 Document and correspondence exchanged between the Department of Health and the Health Minister's office regarding the agreement announced between the Coalition and Pathology Australia on 12 May 2016, and separately, the Coalition and the Australian Diagnostic Imaging Association on 3 June 2016

FOI Request 021-1617 Document
4 documents partial release
032-1617 5 September 2016 Thyroxine Injections

These documents are available on the TGA Disclosure log
1 document released in full

258-1516 23 August 2016 Contracts by the Department of Health in relation to the National Monthly Tobacco Plain Packaging Survey and technical report

FOI Request 258-1516 Document
7 documents partial release
269-1516 12 August 2016 Request for Quotation associated with CN3345075 and awarded to PricewaterhouseCoopers

FOI Request 269-1516 Document
1 document partial release
197-1516 8 August 2016 Results of clinical studies relating to Ferrograd C

These documents are available on the TGA Disclosure log
1 document released in full

In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
244-1516 4 August 2016 Briefs to Minister Ley regarding health workforce modelling for the period 23 December 2014 to 30 May 2016

FOI Request 244-1516 Document
7 documents partial release In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents
230-1516 25 July 2016 First approved product information for Gardasil

These documents are available on the TGA Disclosure log
1 document released in full

260-1516 17 July 2016 CTN Numbers for clinical trials registered through the CTN Scheme

These documents are available on the TGA Disclosure log
1 document released in full

206-1516 7 July 2016 Approval of Gynecare Prolife Pelvic Floor System

These documents are available on the TGA Disclosure log
3 document released in full

In accordance with section 22(1)(a)(ii) of the FOI Act, material irrelevant to the request has been redacted from the documents